New AIDSinfo Drug App Released
AIDSinfo is pleased to announce the release of the AIDSinfo Drug App.Using data from the AIDSinfo Drug Database, the drug app provides information on more than 100 HIV-related approved and investigational drugs. The information, offered in English and Spanish, is tailored to meet the needs of both health care providers and consumers. The app is designed to automatically refresh when the user is connected to a wireless or cellular data network.
The FDA drug labels pulled from DailyMed are integrated into the app in an easy-to-navigate format. This feature, coupled with the auto update feature, makes it easy for health care providers to quickly find the latest drug information when seeing patients. In addition, information from the FDA labels is condensed in easy-to-understand summaries in English and Spanish for consumers. The app also includes information on HIV-related investigational drugs for both health care providers and consumers. It is available for both iOS and Android devices.
Information resources on Ebola virus disease
March 31, 2015. HHS contracts BioCryst Pharmaceuticals of Durham, North Carolina, to develop new Ebola drug, including preparing for large-scale manufacturing of the drug and conducting related studies.
Mar. 26, 2015. Two experimental Ebola Test Vaccines, cAd3-EBOZ and VSV-ZEBOV appear to be safe based on evaluation in more than 600 people in Liberia who participated in the first stage of the Partnership for Research on Ebola Vaccines in Liberia (PREVAIL) Phase 2/3 clinical trial according to interim findings from an independent Data and Safety Monitoring Board review. Based on these findings, the study, which is sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, may now advance to Phase 3 testing.
Ebola vaccines, therapies, and diagnostics. This document from WHO provides answers to questions about clinical trials and evaluations of potential vaccines, therapies, and diagnostics for Ebola virus disease.
There are 35 hospitals with Ebola treatment centers in the United States as of 12/2/2014. In New York the following hospitals are now equipped to treat patients with Ebola: North Shore System LIJ/Glen Cove Hospital, Montefiore Health System, New York-Presbyterian/Allen Hospital, NYC Health and Hospitals Corporation/HHC Bellevue Hospital Center, and The Mount Sinai Hospital.
Interim Guidance for U.S. Hospital Preparedness for Patients with Possible or Confirmed Ebola Virus Disease: A Framework for a Tiered Approach This CDC guidance document released on December 2, 2014 serves as an overarching framework for three other specific CDC guidance documents: Interim Guidance for Preparing Frontline Healthcare Facilities for Patients with Possible Ebola Virus Disease; Interim Guidance for Preparing Ebola Assessment Hospitals; and Interim Guidance for Preparing Ebola Treatment Centers.
Emotional Distress and Concerns About Ebola: The Substance Abuse and Mental Health Services Administration (SAMHSA) provides access to the Disaster Distress Website and the Disaster Distress Hotline 24/7 year round for crisis counseling and support. If you are feeling overwhelmed due to this outbreak, call 1-800-985-5990 for assistance, which is available to anyone affected by the outbreak, including health workers and other responders. SAMHSA launched Ebola new resources to support individuals, communities, and responders in dealing with the Ebola outbreak. These resources include new Tip Sheets on coping with stress and talking to children about the Ebola epidemic, a letter from SAMHSA Administrator, Pam Hyde, and a new Ebola-focused Disaster Behavioral Health information Series collection.
Schedule a PubMed Instruction Class: Whether you are a new PubMed user or want to improve your basic skills, this 50-minute session will prepare you for effective searching for peer-reviewed journal articles.
Schedule a Research Consultation: Research consultations are best for in-depth assistance with complex research assignments.
For brief or basic questions, try the reference desk or e-mail me at: email@example.com